Beta Thalassemia Testing Market

Research Report and Overview on Beta Thalassemia
Testing Market, 2016-2026
December 2016
Report Id : REP-GB-1738
Status : Ongoing
Category : Healthcare, Pharmaceuticals & Medical Devices
©2015 Future Market Insights, All Rights Reserved

About
Future Market Insights
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom
research reports, and consulting services. We deliver a complete packaged solution, which
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC,
ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,
Technology, Healthcare, and Retail.
We have a global presence with delivery centers across India specializing in providing global
research reports and country research reports. FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning
from every corner of the world to distill it to one thing – the perfect solution for our client.
Research Capabilities
Sector Coverage
Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
Subscription Information
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com
©2015 Future Market Insights, All Rights Reserved
2

Research Methodology (1/2)
Systematic Research Approach
Market profiling
Formulating discussion guide
Developing list of respondents
Data collection
Data validation
4
5
3
1
2
In-depth secondary research is used to
ascertain overall market size, top
industry players, top products, industry
associations, etc.
PMR formulates a detailed discussion
guide to conduct expert and industry
interviews
PMR develops a list of industry players
(manufacturers), distributors, retailers
and industry experts
PMR conducts interviews with industry
experts, industry players, distributors
and retailers
Data is validated by triangulation
method, wherein secondary, primary
and PMR analysis contribute to the final
data
Data
Collection
Data Filter
& Analysis
Identifying key opinion leaders
Questionnaire design
In-depth interviews
Coverage across value chain
Market participants
Key strengths
Product portfolio
Mapping as per value chain
Key focus segments
A
Primary
Research
C
Company
Analysis
Research &
Intelligence
SOLUTION
Actionable
Insights
B
Desk
Research
Business
Solution
Key industry experts
Channel study
Developments
Market dynamics
Products
Conclusions
Data analysis
6
Data is scrutinized using MS-Excel to
obtain qualitative and quantitative
insights about the industry
Primary Research #
Secondary Research #
Paid Publications#
Insights
7
PMR delivers industry insights and
information in the required format
(PDF)
Linkedin
Zoominfo
Salesforce
Avention
Company websites
Company annual
reports
White papers
Financial reports
Factiva
GBI
Genios
Meltwater
# includes sources of databases
©2015 Future Market Insights, All Rights Reserved
3

Beta Thalassemia Testing Market
Beta thalassemia can be simplified as a diseased state of blood in which there is reduced hemoglobin
production. Hemoglobin is a protein containing iron and is present in Red blood cells and the major
function of hemoglobin is to carry oxygen to the body cells throughout the body. Low hemoglobin
content in the beta thalassemia patients usually leads to the lack of oxygen in many parts of the body.
Due to shortage of blood in the body patient, skin becomes pale yellow and the other symptoms like
weakness and fatigue are prominent. Risk of abnormal blood clotting highly persist in the patients
suffering from beta thalassemia.
According to the symptoms severity the disease can be classified into three thalassemia major (Cooley's
anemia), thalassemia intermediate and thalassemia minor. Amongst all the forms of thalassemia, major is
considered to be the most dreadful. Diagnostics tests associated with Beta Thalassemia CBC Complete
blood Count: CBC determines the amount of hemoglobin and RBC in the blood. Carriers possess regular
hemoglobin level but may have a marginally reduced count of RBC. Patients having more severe type of
thalassemia will have a lower RBC and hemoglobin levels. The detection of the diseased state comprises
of measuring mean corpuscular volume which is the size of the RBC. Therefore the mean corpuscular
volume is usually found declining in the patients of thalassemia. Hemoglobin tests will show a significant
rise in A2 (>2.5%) and a fall in hemoglobin A (

Beta Thalassemia Testing Market
surrounding the fetus. Blood from the developing fetus can also be as good source of sample for
detecting thalassemia but aspirating blood sample may cause some damage to a developing fetus, hence
taking of amniotic fluid samples is generally preferred. Chorionic Villus sampling (CVS) is another
technique of diagnosing genetic problems in the fetus. Sample is collected from the placental tissue or
chorionic villus. There is risk of miscarriage involved with every prenatal test. Preimplantation genetic
diagnosis (PGD) is a new procedure that may be performed on embryos which are produced by in vitro
fertilization. This test is performed on the embryos which are produced artificially and also allows parents
to carry and implant only those embryos that are not carrying the mutated thalassemia genes.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1738
Most commonly prone area for beta thalassemia are Mediterranean countries, African countries, and
Southeast Asian countries. Thalassemia trait almost affects 5% to 30% of the population in these ethnic
groups. The growing population in these countries act as the drivers for beta thalassemia testing kit
market. A number of factors such as high implementation cost of sophisticated clinical and preclinical
imaging systems, High cost of maintenance, low life span of accessories used are restricting the growth of
the global imaging market.
Based on technology, the beta thalassemia testing Market is segmented into the following:
©2015 Future Market Insights, All Rights Reserved 5

Beta Thalassemia Testing Market
Perinatal Testing
‣ Complete Blood Count (CBC)
‣ DNA Testing
Prenatal Testing
‣ Prenatal Genetic Testing
‣ Chorionic Villus sampling
Preimplantation
Based on end user, the in vivo imaging systems market can be segmented into following:
Hospitals
Biotechnological Laboratories
Diagnostic Laboratories
Educational research institutes
©2015 Future Market Insights, All Rights Reserved 6

Beta Thalassemia Testing Market
Pharmaceutical Industries
Based on geography, the in vivo Imaging Systems market is segmented into following:
North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
Eastern Europe (Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa)
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1738
©2015 Future Market Insights, All Rights Reserved 7

Beta Thalassemia Testing Market
The testing market for beta thalassemia has a growing trend in the countries with ethnic groups like,
Mediterranean countries, African countries and few countries in Asia Pacific. As migration has become
more common, population of beta thalassemia can be seen rising in the developed countries as well.
There are several prenatal test available in the market to determine the possibility of beta thalassemia
including both invasive and noninvasive technique. A recent advancement in the testing of beta
thalassemia may determine the risk of the disease by in vitro examination of the embryo. Even though
there are many such testing available in the market but lack of awareness leads to the negligence and
delayed diagnosis of the diseased state. Approximately 50k – 100k children with β-thalassemia major in
middle and low income countries die every year.
The topical regions are more prone to possess high numbers of patients with beta thalassemia like
Nigeria, Sudan, Chad, Columbia etc. followed by few South Asian countries. Research Institutes and
Pharmaceutical companies, growing usage for beta thalassemia testing and technological advancements,
rising awareness are factors driving market growth. Few Asian countries like Myanmar and Thailand also
have high number of beta thalassemia patients.
Browse Full Report@ http://www.futuremarketinsights.com/reports/beta-thalassemia-testing-market
Click here to
Order a free sample
©2015 Future Market Insights, All Rights Reserved 8

To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
For media queries, contact the press office at
press@futuremarketinsights.com
For other queries contact:
Hari. T (Sr. Manager - Global Business Development)
Future Market Insights: 3rd Floor,
207 Regent Street, London W1B 3HH
T: +44 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com
Thank You
Future Market Insights Global & Consulting Private Limited (FMI)
©2015 Future Market Insights, All Rights Reserved
9